Depression / Major Depressive Disorder
175
63
76
28
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 175 trials
100.0%
+13.5% vs benchmark
6%
10 trials in Phase 3/4
4%
1 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (175)
Lumateperone for Late-Life Depression
Augmented Depression Therapy (ADepT) Case Series
Auditory Stimulation for Insomnia and Depression
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.
Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
Single-case Intervention Study for Visual Screening Assessment for Proof of Concept and Prediction of Clinical Response to Brexiprazole as Adjunctive Treatment in Adults With Major Depressive Disorder.
The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms
Trifecta Research Study
VR-Based Behavioral Activation in Adults
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression
Stress Management and Meditative Movements for Asian Americans With Depression and Physical Symptoms
Neural Correlates of Suicidal Behavior in Youth
Intern Health Study 2026
Narrative Therapy for Anxiety and Depression in Palestinian Refugee Adolescents
EEG Prediction and Clinical Efficacy of tDCS in Major Depression
Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
Debriefing Consult for Psychiatric Symptoms After Severe Maternal Morbidity
Longitudinal Study on the Sustainability of Transcranial Magnetic Stimulation Protocols - Biomarkers